Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 47288-47290 [2011-19829]
Download as PDF
47288
Federal Register / Vol. 76, No. 150 / Thursday, August 4, 2011 / Notices
Type of Review: Clearance of a new
information collection.
Background: The FAA intends to
collect safety-related data regarding the
voluntary implementation of
Commercial Aviation Safety Team
safety enhancements from certificate
holders conducting operations under 14
CFR part 121 and parts 121/135. The
FAA is seeking a generic information
collection request clearance because this
collection will be composed of a series
of individual collections using similar
methods. Certificate-holder
participation in this data collection will
be voluntary and is not required by
regulation. As CAST SEs are finalized,
the FAA will determine the details of
individual information collections in
consultation with CAST and certificate
holders.
Respondents: Approximately 100
certificate holders.
Frequency: Information will be
collected on occasion.
Estimated Average Burden per
Response: 40 minutes.
Estimated Total Annual Burden:
1333.33 hours.
ADDRESSES: Send comments to the FAA
at the following address: Ms. Carla
Scott, Room 336, Federal Aviation
Administration, AES–300, 950 L’Enfant
Plaza, SW., Washington, DC 20024.
Public Comments Invited: You are
asked to comment on any aspect of this
information collection, including (a)
Whether the proposed collection of
information is necessary for FAA’s
performance; (b) the accuracy of the
estimated burden; (c) ways for FAA to
enhance the quality, utility and clarity
of the information collection; and (d)
ways that the burden could be
minimized without reducing the quality
of the collected information. The agency
will summarize and/or include your
comments in the request for OMB’s
clearance of this information collection.
Issued in Washington, DC, on July 28,
2011.
Carla Scott,
FAA Information Collection Clearance
Officer, IT Enterprises Business Services
Division, AES–200.
[FR Doc. 2011–19744 Filed 8–3–11; 8:45 am]
sroberts on DSK5SPTVN1PROD with NOTICES
BILLING CODE 4910–13–P
DEPARTMENT OF TRANSPORTATION
Federal Highway Administration
Notice of Final Federal Agency Actions
on Proposed Highway in California
Federal Highway
Administration (FHWA), DOT.
AGENCY:
VerDate Mar<15>2010
17:29 Aug 03, 2011
Jkt 223001
Notice of Limitation on Claims
for Judicial Review of Actions by the
California Department of Transportation
(Caltrans), pursuant to 23 U.S.C. 327.
ACTION:
The FHWA, on behalf of
Caltrans, is issuing this notice to
announce actions taken by Caltrans, that
are final within the meaning of 23
U.S.C. 139(l)(1). The actions relate to a
proposed highway project along State
Route 15, San Diego, CA, PM: R3.8–R6.0
in the County of San Diego, State of
California. Those actions grant licenses,
permits, and approvals for the project.
DATES: By this notice, the FHWA, on
behalf of Caltrans, is advising the public
of final agency actions subject to 23
U.S.C. 139(l)(1). A claim seeking
judicial review of the Federal agency
actions on the highway project will be
barred unless the claim is filed on or
before January 31, 2012. If the Federal
law that authorizes judicial review of a
claim provides a time period of less
than 180 days for filing such claim, then
that shorter time period still applies.
FOR FURTHER INFORMATION CONTACT:
Jamie Le Dent, Associate Environmental
Planner, Division of Environmental
Analysis, Caltrans, District 11, 4050
Taylor St., San Diego, CA, 91942, Office:
(619) 688–0157, e-mail:
jamie.ledent@dot.ca.gov.
SUMMARY:
Effective
July 1, 2007, the FHWA assigned, and
Caltrans assumed environmental
responsibilities for this project pursuant
to 23 U.S.C. 327. Notice is hereby given
that Caltrans, has taken final agency
actions subject to 23 U.S.C. 139(l)(1) by
issuing licenses, permits, and approvals
for the following highway project in the
State of California: The addition of bus
rapid transit stations and dedicated
lanes along State Route 12 between
Interstate 805 and Interstate 8, in the
City of San Diego.
The actions by the Federal agencies,
and the laws under which such actions
were taken, are described in the Final
Environmental Assessment (EA) for the
project, approved on June 28, 2011 in
the FHWA Finding of No Significant
Impacts (FONSI) issued on June 28,
2011, and in other documents in the
FHWA project records. The Initial Study
& EA/FONSI, and other project records
are available by contacting Caltrans at
the addresses provided above. The
Caltrans Final EA and FONSI can be
viewed and downloaded from the
project Web site at https://
www.dot.ca.gov/dist11/.
This notice applies to all Federal
agency decisions as of the issuance date
of this notice and all laws under which
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00149
Fmt 4703
Sfmt 4703
such actions were taken, including but
not limited to:
1. Council on Environmental Quality
regulations;
2. National Environmental Policy Act
(NEPA);
3. Safe, Accountable, Flexible,
Efficient Transportation Equity Act: A
Legacy for Users (SAFETEA–LU);
4. Department of Transportation Act
of 1966;
5. Federal Aid Highway Act of 1970;
6. Clean Air Act Amendments of
1990;
7. Clean Water Act of 1977 and 1987;
8. Endangered Species Act of 1973;
9. Migratory Bird Treaty Act;
10. Title VI of the Civil Rights Act of
1964;
11. Uniform Relocation Assistance
and Real Property Acquisition Act of
1970;
12. National Historic Preservation Act
of 1966;
13. Historic Sites Act of 1935;
14. Executive Order 11990, Protection
of Wetlands
15. Executive Order 13112, Invasive
Species;
16. Executive Order 11988,
Floodplain Management; and,
17. Executive Order 12898,
Environmental Justice.
(Catalog of Federal Domestic Assistance
Program Number 20.205, Highway Planning
and Construction. The regulations
implementing Executive Order 12372
regarding intergovernmental consultation on
Federal programs and activities apply to this
program.)
Authority: 23 U.S.C. 139(l)(1).
Issued on: July 28, 2011.
Shawn E. Oliver,
South Team Leader, Transportation Engineer,
Federal Highway Administration,
Sacramento, California.
[FR Doc. 2011–19737 Filed 8–3–11; 8:45 am]
BILLING CODE 4910–RY–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2011–0125]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of Final Disposition.
AGENCY:
FMCSA announces its
decision to exempt fifteen individuals
from its rule prohibiting persons with
insulin-treated diabetes mellitus (ITDM)
from operating commercial motor
vehicles (CMVs) in interstate commerce.
SUMMARY:
E:\FR\FM\04AUN1.SGM
04AUN1
Federal Register / Vol. 76, No. 150 / Thursday, August 4, 2011 / Notices
The exemptions will enable these
individuals to operate CMVs in
interstate commerce.
DATES: The exemptions are effective
August 4, 2011. The exemptions expire
on August 5, 2013.
FOR FURTHER INFORMATION CONTACT:
Elaine M. Papp, Chief, Medical
Programs, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
Transportation, 1200 New Jersey
Avenue, SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
sroberts on DSK5SPTVN1PROD with NOTICES
Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey
Avenue, SE., Washington, DC, between
9 a.m. and 5 p.m., Monday through
Friday, except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
Privacy Act Statement for the Federal
Docket Management System (FDMS)
published in the Federal Register on
January 17, 2008 (73 FR 3316), or you
may visit https://edocket.access.gpo.gov/
2008/pdf/E8-785.pdf.
Background
On June 10, 2011, FMCSA published
a notice of receipt of Federal diabetes
exemption applications from fifteen
individuals and requested comments
from the public (76 FR 34127). The
public comment period closed on July
11, 2011 and one comment was
received.
FMCSA has evaluated the eligibility
of the fifteen applicants and determined
that granting the exemptions to these
individuals would achieve a level of
safety equivalent to, or greater than, the
level that would be achieved by
complying with the current regulation
49 CFR 391.41(b)(3).
Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
standard for diabetes in 1970 because
VerDate Mar<15>2010
17:29 Aug 03, 2011
Jkt 223001
several risk studies indicated that
drivers with diabetes had a higher rate
of crash involvement than the general
population. The diabetes rule provides
that ‘‘A person is physically qualified to
drive a commercial motor vehicle if that
person has no established medical
history or clinical diagnosis of diabetes
mellitus currently requiring insulin for
control’’ (49 CFR 391.41(b)(3)).
FMCSA established its diabetes
exemption program, based on the
Agency’s July 2000 study entitled ‘‘A
Report to Congress on the Feasibility of
a Program to Qualify Individuals with
Insulin-Treated Diabetes Mellitus to
Operate in Interstate Commerce as
Directed by the Transportation Act for
the 21st Century.’’ The report concluded
that a safe and practicable protocol to
allow some drivers with ITDM to
operate CMVs is feasible.
The September 3, 2003 (68 FR 52441)
Federal Register notice in conjunction
with the November 8, 2005 (70 FR
67777) Federal Register notice provides
the current protocol for allowing such
drivers to operate CMVs in interstate
commerce.
These fifteen applicants have had
ITDM over a range of 1 to 31 years.
These applicants report no severe
hypoglycemic reactions resulting in loss
of consciousness or seizure, requiring
the assistance of another person, or
resulting in impaired cognitive function
that occurred without warning
symptoms, in the past 12 months and no
recurrent (2 or more) severe
hypoglycemic episodes in the past 5
years. In each case, an endocrinologist
verified that the driver has
demonstrated a willingness to properly
monitor and manage his/her diabetes
mellitus, received education related to
diabetes management, and is on a stable
insulin regimen. These drivers report no
other disqualifying conditions,
including diabetes-related
complications. Each meets the vision
standard at 49 CFR 391.41(b)(10).
The qualifications and medical
condition of each applicant were stated
and discussed in detail in the June 10,
2011, Federal Register notice and they
will not be repeated in this notice.
Discussion of Comment
FMCSA received one comment in this
proceeding. The comment was
considered and discussed below.
An Anonymous individual wanted to
know why drivers who did not hold a
CDL were not allowed to work for so
long.
FMCSA is legislatively required to
make a final determination 180 days
from the date a complete application
has been received and this is often
PO 00000
Frm 00150
Fmt 4703
Sfmt 4703
47289
accomplished in a shorter time frame.
During this 180 day period, the Agency
is legislatively required to publish all
medical exemption requests in the
Federal Register for a 30 day public
comment period, evaluate and respond
to all comments received, and publish a
notice of final disposition to the public
prior to mailing the exemption if
granted.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the diabetes standard in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
To evaluate the effect of these
exemptions on safety, FMCSA
considered medical reports about the
applicants’ ITDM and vision, and
reviewed the treating endocrinologists’
medical opinion related to the ability of
the driver to safely operate a CMV while
using insulin.
Consequently, FMCSA finds that in
each case exempting these applicants
from the diabetes standard in 49 CFR
391.41(b)(3) is likely to achieve a level
of safety equal to that existing without
the exemption.
Conditions and Requirements
The terms and conditions of the
exemption will be provided to the
applicants in the exemption document
and they include the following: (1) That
each individual submit a quarterly
monitoring checklist completed by the
treating endocrinologist as well as an
annual checklist with a comprehensive
medical evaluation; (2) that each
individual reports within 2 business
days of occurrence, all episodes of
severe hypoglycemia, significant
complications, or inability to manage
diabetes; also, any involvement in an
accident or any other adverse event in
a CMV or personal vehicle, whether or
not it is related to an episode of
hypoglycemia; (3) that each individual
provide a copy of the ophthalmologist’s
or optometrist’s report to the medical
examiner at the time of the annual
medical examination; and (4) that each
individual provide a copy of the annual
medical certification to the employer for
retention in the driver’s qualification
file, or keep a copy in his/her driver’s
qualification file if he/she is selfemployed. The driver must also have a
copy of the certification when driving,
for presentation to a duly authorized
Federal, State, or local enforcement
official.
E:\FR\FM\04AUN1.SGM
04AUN1
47290
Federal Register / Vol. 76, No. 150 / Thursday, August 4, 2011 / Notices
Conclusion
Based upon its evaluation of the
fifteen exemption applications, FMCSA
exempts, Richard A. Bosma, Ronnie E.
Combs, Jr., Barbara A. Farrell, Tony D.
Gayles, Dennis E. Hoffman, Joshua D.
Kohl, Clayton K. Lichtenberger, Steven
C. Mulder, Judah A. Nell, Ronald A.
Sherwood, John A. Svedics, Vincent H.
Thomas, Jr., Douglas E. Walter, Peter J.
Wasko and Alfred S. Zaladana from the
ITDM standard in 49 CFR 391.41(b)(3),
subject to the conditions listed under
‘‘Conditions and Requirements’’ above.
In accordance with 49 U.S.C. 31136(e)
and 31315 each exemption will be valid
for two years unless revoked earlier by
FMCSA. The exemption will be revoked
if: (1) The person fails to comply with
the terms and conditions of the
exemption; (2) the exemption has
resulted in a lower level of safety than
was maintained before it was granted; or
(3) continuation of the exemption would
not be consistent with the goals and
objectives of 49 U.S.C. 31136(e) and
31315. If the exemption is still effective
at the end of the 2-year period, the
person may apply to FMCSA for a
renewal under procedures in effect at
that time.
Issued on: July 28, 2011.
Larry W. Minor,
Associate Administrator, Office of Policy.
[FR Doc. 2011–19829 Filed 8–3–11; 8:45 am]
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2011–0144]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of Final Disposition.
AGENCY:
FMCSA announces its
decision to exempt twenty-three
individuals from its rule prohibiting
persons with insulin-treated diabetes
mellitus (ITDM) from operating
commercial motor vehicles (CMVs) in
interstate commerce. The exemptions
will enable these individuals to operate
CMVs in interstate commerce.
DATES: The exemptions are effective
August 4, 2011. The exemptions expire
on August 5, 2013.
FOR FURTHER INFORMATION CONTACT:
Elaine M. Papp, Chief, Medical
Programs, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
sroberts on DSK5SPTVN1PROD with NOTICES
SUMMARY:
17:29 Aug 03, 2011
Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey
Avenue, SE., Washington, DC, between
9 a.m. and 5 p.m., Monday through
Friday, except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
Privacy Act Statement for the Federal
Docket Management System (FDMS)
published in the Federal Register on
January 17, 2008 (73 FR 3316), or you
may visit https://edocket.access.gpo.gov/
2008/pdf/E8–785.pdf.
Background
BILLING CODE 4910–EX–P
VerDate Mar<15>2010
Transportation, 1200 New Jersey
Avenue, SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
Jkt 223001
On June 10, 2011, FMCSA published
a notice of receipt of Federal diabetes
exemption applications from twentythree individuals and requested
comments from the public (76 FR
34130). The public comment period
closed on July 11, 2011 and no
comments were received.
FMCSA has evaluated the eligibility
of the twenty-three applicants and
determined that granting the
exemptions to these individuals would
achieve a level of safety equivalent to or
greater than the level that would be
achieved by complying with the current
regulation 49 CFR 391.41(b)(3).
Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
standard for diabetes in 1970 because
several risk studies indicated that
drivers with diabetes had a higher rate
of crash involvement than the general
population. The diabetes rule provides
that ‘‘A person is physically qualified to
drive a commercial motor vehicle if that
person has no established medical
history or clinical diagnosis of diabetes
mellitus currently requiring insulin for
control’’ (49 CFR 391.41(b)(3)).
PO 00000
Frm 00151
Fmt 4703
Sfmt 4703
FMCSA established its diabetes
exemption program, based on the
Agency’s July 2000 study entitled ‘‘A
Report to Congress on the Feasibility of
a Program to Qualify Individuals with
Insulin-Treated Diabetes Mellitus to
Operate in Interstate Commerce as
Directed by the Transportation Act for
the 21st Century.’’ The report concluded
that a safe and practicable protocol to
allow some drivers with ITDM to
operate CMVs is feasible.
The September 3, 2003 (68 FR 52441)
Federal Register notice in conjunction
with the November 8, 2005 (70 FR
67777) Federal Register notice provides
the current protocol for allowing such
drivers to operate CMVs in interstate
commerce.
These twenty-three applicants have
had ITDM over a range of 1 to 33 years.
These applicants report no severe
hypoglycemic reactions resulting in loss
of consciousness or seizure, requiring
the assistance of another person, or
resulting in impaired cognitive function
that occurred without warning
symptoms, in the past 12 months and no
recurrent (2 or more) severe
hypoglycemic episodes in the past 5
years. In each case, an endocrinologist
verified that the driver has
demonstrated a willingness to properly
monitor and manage his/her diabetes
mellitus, received education related to
diabetes management, and is on a stable
insulin regimen. These drivers report no
other disqualifying conditions,
including diabetes-related
complications. Each meets the vision
standard at 49 CFR 391.41(b)(10).
The qualifications and medical
condition of each applicant were stated
and discussed in detail in the June 10,
2011, Federal Register notice and they
will not be repeated in this notice.
Discussion of Comment
FMCSA did not receive any
comments in this proceeding.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the diabetes standard in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
To evaluate the effect of these
exemptions on safety, FMCSA
considered medical reports about the
applicants’ ITDM and vision, and
reviewed the treating endocrinologists’
medical opinion related to the ability of
the driver to safely operate a CMV while
using insulin.
E:\FR\FM\04AUN1.SGM
04AUN1
Agencies
[Federal Register Volume 76, Number 150 (Thursday, August 4, 2011)]
[Notices]
[Pages 47288-47290]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-19829]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[FMCSA Docket No. FMCSA-2011-0125]
Qualification of Drivers; Exemption Applications; Diabetes
Mellitus
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of Final Disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to exempt fifteen individuals
from its rule prohibiting persons with insulin-treated diabetes
mellitus (ITDM) from operating commercial motor vehicles (CMVs) in
interstate commerce.
[[Page 47289]]
The exemptions will enable these individuals to operate CMVs in
interstate commerce.
DATES: The exemptions are effective August 4, 2011. The exemptions
expire on August 5, 2013.
FOR FURTHER INFORMATION CONTACT: Elaine M. Papp, Chief, Medical
Programs, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Room W64-224,
Department of Transportation, 1200 New Jersey Avenue, SE., Washington,
DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., Monday
through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online through the Federal Document
Management System (FDMS) at: https://www.regulations.gov.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue, SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the electronic form of all comments
received into any of DOT's dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, or other
entity). You may review DOT's Privacy Act Statement for the Federal
Docket Management System (FDMS) published in the Federal Register on
January 17, 2008 (73 FR 3316), or you may visit https://edocket.access.gpo.gov/2008/pdf/E8-785.pdf.
Background
On June 10, 2011, FMCSA published a notice of receipt of Federal
diabetes exemption applications from fifteen individuals and requested
comments from the public (76 FR 34127). The public comment period
closed on July 11, 2011 and one comment was received.
FMCSA has evaluated the eligibility of the fifteen applicants and
determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to, or greater than, the level
that would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).
Diabetes Mellitus and Driving Experience of the Applicants
The Agency established the current standard for diabetes in 1970
because several risk studies indicated that drivers with diabetes had a
higher rate of crash involvement than the general population. The
diabetes rule provides that ``A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control'' (49 CFR 391.41(b)(3)).
FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible.
The September 3, 2003 (68 FR 52441) Federal Register notice in
conjunction with the November 8, 2005 (70 FR 67777) Federal Register
notice provides the current protocol for allowing such drivers to
operate CMVs in interstate commerce.
These fifteen applicants have had ITDM over a range of 1 to 31
years. These applicants report no severe hypoglycemic reactions
resulting in loss of consciousness or seizure, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning symptoms, in the past 12 months and no
recurrent (2 or more) severe hypoglycemic episodes in the past 5 years.
In each case, an endocrinologist verified that the driver has
demonstrated a willingness to properly monitor and manage his/her
diabetes mellitus, received education related to diabetes management,
and is on a stable insulin regimen. These drivers report no other
disqualifying conditions, including diabetes-related complications.
Each meets the vision standard at 49 CFR 391.41(b)(10).
The qualifications and medical condition of each applicant were
stated and discussed in detail in the June 10, 2011, Federal Register
notice and they will not be repeated in this notice.
Discussion of Comment
FMCSA received one comment in this proceeding. The comment was
considered and discussed below.
An Anonymous individual wanted to know why drivers who did not hold
a CDL were not allowed to work for so long.
FMCSA is legislatively required to make a final determination 180
days from the date a complete application has been received and this is
often accomplished in a shorter time frame. During this 180 day period,
the Agency is legislatively required to publish all medical exemption
requests in the Federal Register for a 30 day public comment period,
evaluate and respond to all comments received, and publish a notice of
final disposition to the public prior to mailing the exemption if
granted.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes standard in 49 CFR 391.41(b)(3) if the exemption is
likely to achieve an equivalent or greater level of safety than would
be achieved without the exemption. The exemption allows the applicants
to operate CMVs in interstate commerce.
To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision, and
reviewed the treating endocrinologists' medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes standard in 49 CFR 391.41(b)(3) is likely
to achieve a level of safety equal to that existing without the
exemption.
Conditions and Requirements
The terms and conditions of the exemption will be provided to the
applicants in the exemption document and they include the following:
(1) That each individual submit a quarterly monitoring checklist
completed by the treating endocrinologist as well as an annual
checklist with a comprehensive medical evaluation; (2) that each
individual reports within 2 business days of occurrence, all episodes
of severe hypoglycemia, significant complications, or inability to
manage diabetes; also, any involvement in an accident or any other
adverse event in a CMV or personal vehicle, whether or not it is
related to an episode of hypoglycemia; (3) that each individual provide
a copy of the ophthalmologist's or optometrist's report to the medical
examiner at the time of the annual medical examination; and (4) that
each individual provide a copy of the annual medical certification to
the employer for retention in the driver's qualification file, or keep
a copy in his/her driver's qualification file if he/she is self-
employed. The driver must also have a copy of the certification when
driving, for presentation to a duly authorized Federal, State, or local
enforcement official.
[[Page 47290]]
Conclusion
Based upon its evaluation of the fifteen exemption applications,
FMCSA exempts, Richard A. Bosma, Ronnie E. Combs, Jr., Barbara A.
Farrell, Tony D. Gayles, Dennis E. Hoffman, Joshua D. Kohl, Clayton K.
Lichtenberger, Steven C. Mulder, Judah A. Nell, Ronald A. Sherwood,
John A. Svedics, Vincent H. Thomas, Jr., Douglas E. Walter, Peter J.
Wasko and Alfred S. Zaladana from the ITDM standard in 49 CFR
391.41(b)(3), subject to the conditions listed under ``Conditions and
Requirements'' above.
In accordance with 49 U.S.C. 31136(e) and 31315 each exemption will
be valid for two years unless revoked earlier by FMCSA. The exemption
will be revoked if: (1) The person fails to comply with the terms and
conditions of the exemption; (2) the exemption has resulted in a lower
level of safety than was maintained before it was granted; or (3)
continuation of the exemption would not be consistent with the goals
and objectives of 49 U.S.C. 31136(e) and 31315. If the exemption is
still effective at the end of the 2-year period, the person may apply
to FMCSA for a renewal under procedures in effect at that time.
Issued on: July 28, 2011.
Larry W. Minor,
Associate Administrator, Office of Policy.
[FR Doc. 2011-19829 Filed 8-3-11; 8:45 am]
BILLING CODE 4910-EX-P